Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

维臻高 - NMPA Drug Approval Details

Approvals/NMPA/维臻高

Approved

生物制品

维臻高

Unknown🇨🇳 National Medical Products Administration

Approval Date: Jan 20, 2026
Approval ID: 8n95igZrn3M
Company: Unknown
Type: 生物制品

Approval Details

Approval Id: 8n95igZrn3M
Approval Number: 国药准字SJ20260007
Generic Name: 注射用隆培生长激素
Trade Name: 维臻高
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 6.3 mg（以生长激素计）/支
Reg Date: 2026-01-20
Expired Date: 2031-01-19

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 20, 2026

Approval ID

8n95igZrn3M

Type

生物制品

Back to NMPA Approvals